| Product Code: ETC8842143 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The geographic atrophy market in the Philippines is gaining attention due to the increasing prevalence of age-related macular degeneration (AMD). Pharmaceutical companies are developing new treatment options, including gene therapies and anti-inflammatory drugs, to address this condition. Rising awareness and improved healthcare facilities are also driving market growth.
The increasing prevalence of age-related macular degeneration (AMD) in the Philippines is driving demand for geographic atrophy treatments. The rising geriatric population, which is more prone to vision disorders, is further fueling market growth. Advances in ophthalmic treatments, including gene therapy and stem cell research, are improving patient outcomes and expanding market opportunities. Additionally, increased healthcare spending and greater access to diagnostic services are supporting early detection and management of the disease.
The geographic atrophy market in the Philippines is hindered by limited awareness, high treatment costs, and inadequate healthcare infrastructure. Many patients and healthcare providers are unaware of geographic atrophy as a progressive eye disease, leading to late diagnoses and poor treatment outcomes. Advanced treatments for this condition are expensive, making them inaccessible to a significant portion of the population. Furthermore, specialized ophthalmology services are concentrated in urban centers, leaving rural areas underserved.
The increasing prevalence of age-related macular degeneration (AMD) is driving demand for treatments targeting geographic atrophy in the Philippines. Investors can explore opportunities in pharmaceutical development, clinical trials, and healthcare partnerships. Advancements in gene therapy and targeted drug treatments create long-term growth prospects in this market.
The DOH regulates treatments for geographic atrophy, a form of age-related macular degeneration, ensuring that pharmaceutical solutions comply with safety standards. The government supports research into innovative treatments and aims to improve patient access to emerging therapies. PhilHealth coverage for vision-related diseases is being expanded to include more treatment options for geographic atrophy.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Geographic Atrophy Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Geographic Atrophy Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Geographic Atrophy Market - Industry Life Cycle |
3.4 Philippines Geographic Atrophy Market - Porter's Five Forces |
3.5 Philippines Geographic Atrophy Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.6 Philippines Geographic Atrophy Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Philippines Geographic Atrophy Market Revenues & Volume Share, By Therapeutic Agents Clinical Phase, 2021 & 2031F |
4 Philippines Geographic Atrophy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Geographic Atrophy Market Trends |
6 Philippines Geographic Atrophy Market, By Types |
6.1 Philippines Geographic Atrophy Market, By Age Group |
6.1.1 Overview and Analysis |
6.1.2 Philippines Geographic Atrophy Market Revenues & Volume, By Age Group, 2021- 2031F |
6.1.3 Philippines Geographic Atrophy Market Revenues & Volume, By Above 60 Years, 2021- 2031F |
6.1.4 Philippines Geographic Atrophy Market Revenues & Volume, By Above 75 Years, 2021- 2031F |
6.2 Philippines Geographic Atrophy Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Philippines Geographic Atrophy Market Revenues & Volume, By Fundus Autofluorescence (FAF), 2021- 2031F |
6.2.3 Philippines Geographic Atrophy Market Revenues & Volume, By Optical Coherence Tomography Angiography (OCT-A), 2021- 2031F |
6.2.4 Philippines Geographic Atrophy Market Revenues & Volume, By Multifocal Electroretinography (MfERG), 2021- 2031F |
6.3 Philippines Geographic Atrophy Market, By Therapeutic Agents Clinical Phase |
6.3.1 Overview and Analysis |
6.3.2 Philippines Geographic Atrophy Market Revenues & Volume, By Late-Stage (Phase III), 2021- 2031F |
6.3.3 Philippines Geographic Atrophy Market Revenues & Volume, By Phase II, 2021- 2031F |
6.3.4 Philippines Geographic Atrophy Market Revenues & Volume, By Phase I, 2021- 2031F |
7 Philippines Geographic Atrophy Market Import-Export Trade Statistics |
7.1 Philippines Geographic Atrophy Market Export to Major Countries |
7.2 Philippines Geographic Atrophy Market Imports from Major Countries |
8 Philippines Geographic Atrophy Market Key Performance Indicators |
9 Philippines Geographic Atrophy Market - Opportunity Assessment |
9.1 Philippines Geographic Atrophy Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.2 Philippines Geographic Atrophy Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Philippines Geographic Atrophy Market Opportunity Assessment, By Therapeutic Agents Clinical Phase, 2021 & 2031F |
10 Philippines Geographic Atrophy Market - Competitive Landscape |
10.1 Philippines Geographic Atrophy Market Revenue Share, By Companies, 2024 |
10.2 Philippines Geographic Atrophy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here